| Line 78: | Line 78: | ||
==Consumers== | ==Consumers== | ||
===2023: [https://pubmed.ncbi.nlm.nih.gov/37195899/ Individual and conjoint factors associated with beliefs about the harmfulness of nicotine replacement therapies relative to combustible cigarettes among people who smoke: Findings from the 2020 ITC Four Country Smoking and Vaping Survey]=== | |||
*Data analyzed came from 8,642 adults (18+ years) who smoked daily/weekly and participated in the 2020 ITC Four Country Smoking and Vaping Survey in Australia (n=1213), Canada (n=2633), England (n=3057), and United States (US, n=1739). | |||
*Many people who regularly smoke cigarettes are unaware that NRTs are much less harmful than cigarettes. Additionally, beliefs about NRTs relative harmfulness appear to be influenced by both individual and conjoint factors. | |||
===2022: [https://pubmed.ncbi.nlm.nih.gov/35368082/ Do smokers' perceptions of the harmfulness of nicotine replacement therapy and nicotine vaping products as compared to cigarettes influence their use as an aid for smoking cessation? Findings from the ITC Four Country Smoking and Vaping Surveys]=== | ===2022: [https://pubmed.ncbi.nlm.nih.gov/35368082/ Do smokers' perceptions of the harmfulness of nicotine replacement therapy and nicotine vaping products as compared to cigarettes influence their use as an aid for smoking cessation? Findings from the ITC Four Country Smoking and Vaping Surveys]=== | ||
*We analyzed data from 1,315 current daily smokers (10+ cigarettes per day) who were recruited at Wave 1 (2016), and who reported making a quit attempt by Wave 2 (2018) of the International Tobacco Control Four Country Smoking and Vaping Surveys in Australia, Canada, England, and the United States. | *We analyzed data from 1,315 current daily smokers (10+ cigarettes per day) who were recruited at Wave 1 (2016), and who reported making a quit attempt by Wave 2 (2018) of the International Tobacco Control Four Country Smoking and Vaping Surveys in Australia, Canada, England, and the United States. | ||
*Consistent with past studies,our findings confirm that harm perceptions influence nicotine product use, with accurate perceptions associated with greater likelihood of use as a smoking cessation aid, whereas inaccurate perceptions appear to deter their use for this purpose. | *Consistent with past studies,our findings confirm that harm perceptions influence nicotine product use, with accurate perceptions associated with greater likelihood of use as a smoking cessation aid, whereas inaccurate perceptions appear to deter their use for this purpose. | ||
===2022: [https://stories.uq.edu.au/medicine/2020/clarifying-australia-s-youth-vaping-figures/index.html Clarifying Australia’s youth vaping figures]=== | ===2022: [https://stories.uq.edu.au/medicine/2020/clarifying-australia-s-youth-vaping-figures/index.html Clarifying Australia’s youth vaping figures]=== | ||
*The incorrect reporting of Australia’s purported ‘youth vaping epidemic’ has been used to argue for even tougher restrictions on access to nicotine vaping products. We should be restricting access to the nicotine product that causes the greatest harm in Australia, tobacco cigarettes. Cigarettes are still used by 2.9 million Australians who easily access them at retail outlets, despite being the leading preventable cause of disease burden. | *The incorrect reporting of Australia’s purported ‘youth vaping epidemic’ has been used to argue for even tougher restrictions on access to nicotine vaping products. We should be restricting access to the nicotine product that causes the greatest harm in Australia, tobacco cigarettes. Cigarettes are still used by 2.9 million Australians who easily access them at retail outlets, despite being the leading preventable cause of disease burden. | ||
===2019: [https://pubmed.ncbi.nlm.nih.gov/31486151/ Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia]=== | ===2019: [https://pubmed.ncbi.nlm.nih.gov/31486151/ Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia]=== | ||
edits